Risedronate slows or partly reverses cortical and trabecular microarchitectural deterioration in postmenopausal women.
During early menopause, steady-state bone remodeling is perturbed; the number of basic multicellular units (BMUs) excavating cavities upon the endosteal surface exceeds the number (generated before menopause) concurrently refilling. Later in menopause, steady-state is restored; the many BMUs generat...
Main Authors: | Bala, Y, Chapurlat, R, Cheung, A, Felsenberg, D, LaRoche, M, Morris, E, Reeve, J, Thomas, T, Zanchetta, J, Bock, O, Ghasem-Zadeh, A, Djoumessi, R, Seeman, E, Rizzoli, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2014
|
Similar Items
-
RISEDRONATE REDUCES MICRO-STRUCTURAL DETERIORATION OF CORTICAL BONE ACCOMPANYING MENOPAUSE
by: Seeman, E, et al.
Published: (2010) -
Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass
by: Sahar Mohsin, et al.
Published: (2019-01-01) -
Trabecular microarchitecture in cervical vertebrae
by: Manzanares Cespedes, M, et al.
Published: (2009) -
Assessment of bone mineral density by DXA and the trabecular microarchitecture of the calcaneum by texture analysis in pre- and postmenopausal women in the evaluation of osteoporosis
by: Karunanithi R, et al.
Published: (2007-01-01) -
Once-monthly risedronate for postmenopausal osteoporosis
by: Kristina Casadei, et al.
Published: (2009-02-01)